EARLY ONSET PREECLAMPSIA: MATERNALAND PERINATAL OUTCOME

Preeclampsia is a heterogeneous clinical syndrome which is a leading cause of maternal, fetal, and neonatal morbidity and mortality. The aim of the study evaluate the maternal and fetal outcome in women with diagnosis of early onset preeclampsia. The present study was conducted with the primary objective to study the maternal, fetal and neonatal outcome among women diagnosed with early onset of preeclampsia without severe feature and with severe features. The overall outcome in women where pregnancies were continued after giving Mgso4 therapy were also studied. This was a prospective hospital based study in which 119 pregnant women were enrolled from emergency ward (labour room) who were diagnosed to have early onset preeclampsia at less than 32 weeks of gestation. Women with early onset preeclampsia were given expectant management and the maternal and perinatal outcome in women were reviewed as per severity that is whether PE occurred with or without severe features. The maternal complications did not increase in women who received expectant management in women with PE with severe features, as well as the group which had received prophylactic Mgso4 therapy and in whom subsequently pregnancy continued for few days to weeks. The perinatal outcome was compromised because of early presentation of PE which probably causes the placental insufficiency even in women without severe features. Significant number of days gained during expectant management has an impact on the perinatal outcome which was from few days to weeks in this study.